Holen Sie sich die Stockscreener-App
1,004.20
0.20%
-2.87
Argen X Se Adr Aktie (ARGX) Neueste Nachrichten
Argenx Se Stock Price Forecast. Should You Buy ARGX? - StockInvest.us
argenx SEADR Key Financial Ratios – Valuation, Profitability & More - Value Research
argenx to Present at Upcoming Investor Conferences - Barchart.com
Resilient Argenx stock holds near record highs after Forte Biosciences acquisition - AD HOC NEWS
Resilient Argenx stock touches fresh all-time high after Forte Biosciences deal - AD HOC NEWS
argenx Completes Acquisition of Forte Biosciences, Inc. - Barchart.com
Argenx stock hits all-time high at 1059.86 USD - Investing.com
UBS upgrades argenx stock rating on Vyvgart sales outlook - Investing.com
Analysts Are Bullish on Top Healthcare Stocks: Enliven Therapeutics (ELVN), Argenx Se (ARGX) - The Globe and Mail
Deutsche Bank downgrades argenx stock to Hold on valuation By Investing.com - Investing.com Nigeria
Deutsche Bank downgrades argenx stock to Hold on valuation - Investing.com
ETFs Investing in argenx SE Sponsored ADR Stocks - TradingView
Resilient Argenx stock climbs after positive myositis data and fresh analyst targets - Ad-hoc-news.de
RBC Capital raises argenx stock price target on myositis data - Investing.com
Strong Argenx stock extends rally after Vyvgart trial win and analyst target hikes. - Ad-hoc-news.de
Gold Gains 1%; NY Empire State Manufacturing Index Rises In August - Sahm
Citizens raises argenx stock price target to $1,200 on trial results - Investing.com
Argenx's Positive Vyvgart Data in Autoimmune Indication Supports Growth and FB102 Broadens Portfolio - Morningstar
Resilient Argenx stock jumps after positive Vyvgart Phase 3 data - Ad-hoc-news.de
TD Cowen raises argenx stock price target to $1,353 on myositis outlook - Investing.com Australia
ARGX Stock Price, Quote & Chart - ChartMill
European ADRs Started The Week Slightly Higher In US Trading - Finimize
There are notable gap-ups and gap-downs in today's session. - ChartMill
H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Movi - Benzinga
Argx stock hits all-time high at 954.5 USD By Investing.com - Investing.com Canada
argenx SE (ARGX) Stock Price, News, Quote & History - Yahoo Finance
argenx reports positive Phase 3 ALKIVIA results - grafa.com
Zai Lab, argenx report positive phase 3 data for myositis drug - Investing.com India
Why is Argen-X stock surging today? - Investing.com
Why is Argen-X stock surging today? By Investing.com - Investing.com India
Argenx shares jump after positive Phase 3 results in autoimmune myositis trial - Investing.com South Africa
argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis - Barchart.com
T. Rowe Price (ARGX) discloses 2.68M argenx SE ADRs with 4.3% ownership - Stock Titan
Forte Biosciences earnings on deck as $2.2 billion argenx deal nears - Investing.com
Argenx stock holds near recent highs as half year 2026 update and Forte deal shape outlook - AD HOC NEWS
Weekly Recap: Cash tender offer for Forte and EGM on director appointments - TradingView
Galapagos ADR Representing Ord Shs (LKFT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
argenx launches tender offer for Forte Biosciences at $77 per share - Investing.com
argenx Announces Commencement of Tender Offer to Acquire Forte Biosciences, Inc. - Barchart.com
argenx announces Extraordinary General Meeting of Shareholders on September 17, 2026 - Barchart.com
The Charts Reveal Significant Price Movement in Forte Biosciences Stock Ahead of Argenx’s Acquisition Announcement - Barchart.com
Argenx stock price target held at $940 by H.C. Wainwright on acquisition - Investing.com South Africa
Crude Oil Falls Sharply; US Durable Goods Orders Increase 0.3% In June - Benzinga
Baker Hughes Posts Upbeat Q2 Earnings, Joins Forte Biosciences, Eikon Therapeutics And Other Big Stocks M - Benzinga
argenx SE (ARGX) stock price, news, quote and history - Yahoo Finance UK
argenx to buy Forte Biosciences in a deal worth $2.2 billion - grafa.com
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket - Benzinga
Argenx to buy Forte Biosciences for $2.2 billion to expand immunology pipeline - Investing.com UK
Weekly Recap: Q2 sales and profit surge and Empasiprubart readout schedule - TradingView
argenx SE Sponsored ADR Revenue Breakdown – DUS:1AEA - TradingView
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Brainsway (BWAY) and Argenx Se (ARGX) - The Globe and Mail
argenx SE ADR Unsponsored Brazilian Depositary Receipt Repr 0.04 ADR - TradingView
RBC Capital raises argenx stock price target to $1,025 on strong Vyvgart sales - Investing.com
H.C. Wainwright reiterates argenx stock rating on strong sales - Investing.com
Guggenheim raises argenx stock price target to $1,185 on strong sales - Investing.com
Citizens cuts argenx stock price target to $932 on valuation - Investing.com
Citizens cuts argenx stock price target to $932 on valuation By Investing.com - Investing.com Canada
Argenx's Robust Vyvgart Growth Drives Margin Expansion as Pipeline Advances - Morningstar
European ADRs Slipped In US Trading Late Thursday - Finimize
1.86%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):